Net prices that health plans paid for medicines rose a modest 0.4% in the fourth quarter, but that compared unfavorably with a 3% decline in the same period a year earlier.
The makers of Wegovy and Zepbound are cutting prices to make the medications more affordable for people without insurance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback